Skip to main content
. 2011 Jul 26;137(9):1371–1377. doi: 10.1007/s00432-011-1007-z

Table 1.

The clinic-pathological features of the patients

Total (n = 56) Neck node metastasis
n (%) n (%)
T1
T2 22 39.3 6 27.3
T3 24 42.8 13 54.2
T4 10 17.9 4 40
Cath-D + (50% and up) 8 14.3 6 75
Cath-D − (Lower than 50%) 48 85.7 17 35.4
E-Cath 25% (negative) 9 16.1 5 55.6
E-Cath 25–75% (reduced) 32 57.1 13 40.6
E-Cath 75% (protected) 15 26.8 5 33.3
Cath-D + E-Cath 25% 2 3.6 2 100
Cath-D + E-Cath 25–75% 5 8.9 4 80
Cath-D + E-Cath 75% 1 1.8 0 0
Cath-D − E-Cath 25% 7 12.5 3 42.9
Cath-D − E-Cath 25–75% 27 48.2 9 33.3
Cath-D − E-Cath 75% 14 25 5 35.7

The metastatic neck lymph nodes rates were found in patients according to Cathepsin D, E-Cadherin expression levels and T stages